Premarket Decliner
PCSA Processa Pharmaceuticals3.05+0.46+17.8%
Premarket:2.18-0.87 (-28.5%)
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
Globe NewswireWed, 29-Jul 7:30 AM
